Endothelial Monocyte-activating Polypeptide-II
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Endothelial Monocyte-activating Polypeptide-II, covering 2023-05-03 to 2023-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients [Phase 4]